Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

被引:116
作者
Viallard, JF
Solanilla, A
Gauthier, B
Contin, C
Déchanet, J
Grosset, C
Moreau, JF
Praloran, V
Nurden, P
Pellegrin, JL
Nurden, AT
Ripoche, J
机构
[1] Hop Haut Leveque, Dept Internal Med, F-33604 Pessac, France
[2] Hop Haut Leveque, Dept Hematol, F-33604 Pessac, France
[3] Univ Bordeaux 2, UMR 5540, F-33076 Bordeaux, France
[4] Univ Bordeaux 2, UMR 5533 CNRS, F-33076 Bordeaux, France
关键词
D O I
10.1182/blood.V99.7.2612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD40 ligand (CD40L) is expressed on activated CD4(+) T lymphocytes and at the activated platelet surface. A circulating soluble form of CD40L (sCD40L) is generated by the way of a proteolytic cleavage. We measured sCD40L in the plasma of either healthy subjects; patients with inflammatory disorders and low, normal, or high platelet count (reactive thrombocytosis); or patients with essential thrombocythemia (ET). A tight correlation was found between the platelet count and plasma sCD40L. ET patients had the highest levels of sCD40L. Platelet-associated CD40L was increased in ET and reactive thrombocytosis, conditions associated with increased platelet regeneration. Platelet-associated CD40L was released upon platelet activation. In conclusion, platelets appear as a reservoir of CD40L that may be a major contributor to circulating sCD40L Platelet-associated CD40L may be a potential marker of platelet regeneration. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:2612 / 2614
页数:3
相关论文
共 16 条
[1]  
ANDRE P, 2001, THROMB HAEMOST S
[2]   Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina -: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes [J].
Aukrust, P ;
Müller, F ;
Ueland, T ;
Berget, T ;
Aaser, E ;
Brunsvig, A ;
Solum, NO ;
Forfang, K ;
Froland, SS ;
Gullestad, L .
CIRCULATION, 1999, 100 (06) :614-620
[3]   CALCIUM INVOLVEMENT IN AMINOPHOSPHOLIPID EXPOSURE AND MICROPARTICLE FORMATION DURING PLATELET ACTIVATION - A STUDY USING CA2+-ATPASE INHIBITORS [J].
DACHARYPRIGENT, J ;
PASQUET, JM ;
FREYSSINET, JM ;
NURDEN, AT .
BIOCHEMISTRY, 1995, 34 (36) :11625-11634
[4]   A SOLUBLE FORM OF TRAP (CD40 LIGAND) IS RAPIDLY RELEASED AFTER T-CELL ACTIVATION [J].
GRAF, D ;
MULLER, S ;
KORTHAUER, U ;
VANKOOTEN, C ;
WEISE, C ;
KROCZEK, RA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1749-1754
[5]   The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40 [J].
Henn, V ;
Steinbach, S ;
Büchner, K ;
Presek, P ;
Kroczek, RA .
BLOOD, 2001, 98 (04) :1047-1054
[6]   CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells [J].
Henn, V ;
Slupsky, JR ;
Gräfe, M ;
Anagnostopoulos, I ;
Förster, R ;
Müller-Berghaus, G ;
Kroczek, RA .
NATURE, 1998, 391 (6667) :591-594
[7]   Platelet CD40 ligand (CD40L) -: subcellular localization, regulation of expression, and inhibition by clopidogrel [J].
Hermann, A ;
Rauch, BH ;
Braun, M ;
Schrör, K ;
Weber, AA .
PLATELETS, 2001, 12 (02) :74-82
[8]   The soluble CD40 ligand sCD154 in systemic lupus erythematosus [J].
Kato, K ;
Santana-Sahagún, E ;
Rassenti, LZ ;
Weisman, MH ;
Tamura, N ;
Kobayashi, S ;
Hashimoto, H ;
Kipps, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) :947-955
[9]   Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes [J].
Koshy, M ;
Berger, D ;
Crow, MK .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :826-837
[10]  
Macchi L, 1996, THROMB HAEMOSTASIS, V76, P1020